UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 696.8	$ 681.8
Short-term investments	50.0	50.0
Accounts receivable, net	326.0	335.3
Inventories	700.7	692.3
Other current assets	172.7	165.6
Total current assets	1,946.2	1,925.0
Property, plant and equipment, net	384.1	395.5
Goodwill	313.3	320.4
Intangible assets, net	213.4	229.1
Other long-term assets	177.9	179.0
Total assets	3,034.9	3,049.0
Current liabilities:
Current portion of long-term debt	108.4	2.2
Accounts payable	152.3	134.6
Customer advances	182.2	189.2
Other current liabilities	500.6	465.9
Total current liabilities	943.5	791.9
Long-term debt	715.8	842.3
Other long-term liabilities	393.9	440.5
Commitments and contingencies (Note 14)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 174,132,743 and 174,045,610 shares issued and 151,543,485 and 151,987,081 shares outstanding at March 31, 2021 and December 31, 2020, respectively	1.7	1.7
Treasury stock, at cost, 22,589,258 and 22,058,529 shares at March 31, 2021 and December 31, 2020	(699.8)	(667.0)
Accumulated other comprehensive (loss) income	(12.1)	3.7
Other shareholders' equity	1,677.9	1,622.8
Total shareholders' equity attributable to Bruker Corporation	967.7	961.2
Noncontrolling interest in consolidated subsidiaries	14.0	13.1
Total shareholders' equity	981.7	974.3
Total liabilities and shareholders' equity	$ 3,034.9	$ 3,049.0